Chronic myeloid leukemia, or CML, is a blood cancer affecting the myeloid group of developing blood cells.
CML stands for chronic myeloid leukemia. It is a blood cancer affecting the myeloid group of developing blood cells, which normally gives rise to red blood cells, platelets, and several kinds of white blood cells. The diagnosis is more specific than a general change in a blood count.
BCR-ABL1 is a fusion gene, which means that parts of two genes, BCR and ABL1, have joined. Testing for this fusion gene is central to the assessment of CML. The molecular test result provides important evidence, but the name of the test and the name of the condition are not interchangeable. Results require clinical and laboratory interpretation.

BaluMed makes medicine understandable! Our extensive medical report explanation 'translates' complex medical terms from MRI findings and discharge summaries into easily understandable language. With a combination of artificial intelligence and medical expertise, we offer quickly available and reliable information.